ANUA, a Korean skincare brand, achieved over 200% annual U.S. growth in 2024. It also became TikTok Shop's top beauty brand by revenue that year, according to the Los Angeles Times. This rapid ascent highlights a significant shift in consumer preference within the K-Beauty market, emphasizing efficacy and digital reach. The brand's unexpected dominance on a trend-driven social media platform demonstrates a new path for science-backed products in 2026.
Pharmaceutical companies traditionally focus on medical products and research. However, they are now aggressively dominating mainstream beauty retail with scientifically-backed derma cosmetic brands. Korean pharmaceutical companies are expanding these derma cosmetics beyond pharmacies into mainstream beauty retail and overseas markets, reports KBR. This move challenges the established beauty industry structure.
Based on their rapid sales growth, strategic global expansion, and celebrity endorsements, pharmaceutical-backed derma cosmetics are poised to redefine the global K-Beauty landscape. These brands prioritize clinical efficacy, directly challenging traditional beauty marketing strategies. This trend signals a fundamental shift in consumer priorities, where scientifically-backed efficacy is now a more potent sales driver than traditional luxury branding.
Pharma's Strategic Pivot to Skincare
Korean pharmaceutical companies are actively entering the beauty market, shifting their medical expertise toward skincare. Dongkook Pharmaceutical's Centellian24 brand surpassed 93 million units in cumulative sales for its Madeca Cream product, according to KBRMadeca Cream product, according to KBR. The brand also achieved over 1 trillion won in cumulative sales since its launch. These figures demonstrate the substantial commercial viability of derma cosmetic lines.
The widespread entry by established pharmaceutical giants indicates a calculated move to capture a significant share of the global beauty market. Their diversified brand portfolios and international retail presence suggest a long-term strategy focused on market dominance. Companies failing to integrate genuine scientific credibility into their beauty offerings risk being outmaneuvered by pharmaceutical giants like Dongkook Pharmaceutical, whose Centellian24 brand proves medical heritage can translate directly into mass-market dominance.
